"Anorexia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
Descriptor ID |
D000855
|
MeSH Number(s) |
C23.888.821.108
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Anorexia".
Below are MeSH descriptors whose meaning is more specific than "Anorexia".
This graph shows the total number of publications written about "Anorexia" by people in this website by year, and whether "Anorexia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anorexia" by people in Profiles.
-
Harrop EN, Hutcheson R, Harner V, Mensinger JL, Lindhorst T. "You Don't Look Anorexic": Atypical anorexia patient experiences of weight stigma in medical care. Body Image. 2023 Sep; 46:48-61.
-
Avraham Y, Van Heukelom B, Zolotarev O, Magen I, Vorobiev L, Zwas DR. Insulin normalized brain metabolic status on a Model of Anorexia Nervosa in Mice. Physiol Behav. 2022 05 15; 249:113738.
-
Allen ND, Leung JG, Betcher HK, Borreggine KL, Hosker DK, Minton BA, Sukiennik EM, Wilson JJ, Philbrick KL, Rasmussen KG. Mirtazapine for Symptomatic Relief on a Psychiatric Consultation Service: A Case Series. Psychosomatics. 2016 Jul-Aug; 57(4):409-13.
-
Woodward MR, Harper DG, Stolyar A, Forester BP, Ellison JM. Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms. Am J Geriatr Psychiatry. 2014 Apr; 22(4):415-9.
-
Nemunaitis J, Eiseman I, Cunningham C, Senzer N, Williams A, Lenehan PF, Olson SC, Bycott P, Schlicht M, Zentgraff R, Shin DM, Zinner RG. Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer. Clin Cancer Res. 2005 May 15; 11(10):3846-53.
-
Mitchell EP, Schein PS. Gastrointestinal toxicity of chemotherapeutic agents. Semin Oncol. 1982 Mar; 9(1):52-64.